Search Results for:
IBEC is strengthened by the addition of three new research groups in advanced and emerging therapies
IBEC kicks off 2024 with the incorporation of three new research groups led by Manuel Salmerón Sánchez, Zaida Álvarez Pinto, and Xavier Rovira Clavé. With these additions, IBEC strengthens its position in the field of advanced and emerging therapies.
CATCAT Mechanobiology Morning
Cell and Tissue Research in Catalonia (CATCAT) brings together research groups from different institutes, focusing on understanding cellular and molecular mechanisms driving fundamental biological processes. This new session will be … Read more
Organoids to study ataxia telangiectasia
Núria Montserrat Pulido, principal investigator at IBEC, will lead a project to study Ataxia telangiectasia thanks to funding from AEFAT, the Spanish ataxia-telangiectasia family association. The idea of the project is to obtain cells with the patient mutations, develop organoids, explore the possibility of gene editing processes for different mutations and create a platform for drug testing.
@ Transversal Skills January 12th
On January 12th I introduced me & my work @ Transversal Skills.I presented my artistic work with regard to the connecting themes of human-animal studies, posthumanism and queer studies and … Read more
Barcelona Health Innovation Week
This event will be held in Spanish and Catalan. REPTES EN INNOVACIÓ EN MEDICINA PERSONALITZADA I TERÀPIES EMERGENTS Aquesta taula rodona abordarà alguns dels reptes actuals de la medicina personalitzada … Read more
IBEC Advocates for Open Science in Spain
IBEC will enhance its scientific information system and further implement its open science policy with the assistance of María de Guzmán from FECYT.
